Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CSER _CC_NCGL, |
RCV000148764 | SCV000190501 | uncertain significance | Gorlin syndrome | 2014-06-01 | criteria provided, single submitter | research | Low GERP score may suggest that this variant may belong in a lower pathogenicity class |
Gene |
RCV001719925 | SCV000521004 | likely benign | not provided | 2020-02-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16508594, 25637381) |
Invitae | RCV000148764 | SCV000549093 | likely benign | Gorlin syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001010476 | SCV001170680 | likely benign | Hereditary cancer-predisposing syndrome | 2020-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003415984 | SCV004116288 | uncertain significance | PTCH1-related condition | 2022-10-26 | criteria provided, single submitter | clinical testing | The PTCH1 c.1234G>T variant is predicted to result in the amino acid substitution p.Ala412Ser. This variant was reported in an individual with nevoid basal cell carcinoma syndrome (Pruvost-Balland et al. 2006. PubMed ID: 16508594). This variant is reported in 0.0080% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-98240450-C-A) and has conflicting interpretations in ClinVar of likely benign and uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/161357/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Diagnostic Laboratory, |
RCV001719925 | SCV001963410 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001719925 | SCV001965049 | likely benign | not provided | no assertion criteria provided | clinical testing |